baby powder

Photo
06.04.2023 • News

Plaintiffs Reject newest J&J Talc Litigation Offer

Seeking to clear billions of dollars worth of litigation claiming that its iconic baby powder causes cancer, Johnson & Johnson has announced it is now prepared to offer a payout of $8.9 billion over 25 years to resolve all claims.

Photo
02.02.2023 • News

US Court Rules against J&J Bankruptcy Scheme

A US federal appeals court panel has unanimously dismissed an attempt by Johnson & Johnson to use a controversial procedure that could resolve claims from lawsuits claiming the healthcare group’s talc-based baby powder caused their cancer.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.